J. Didsbury

发表

Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α

M. Lambert, W. Rocque, S. Jin, 1997, Nature.

Purification and characterization of an ADP-ribosyltransferase produced by Clostridium limosum.

J. Vandekerckhove, K. Aktories, J. Van Damme, 1992, The Journal of biological chemistry.

Cross-desensitization of receptors for peptide chemoattractants. Characterization of a new form of leukocyte regulation.

R. Snyderman, E. Tomhave, R. Richardson, 1994, Journal of immunology.

NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint.

A. Baldwin, J. Cogswell, C. E. Brown, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Modification of the rat adipocyte A1 adenosine receptor-adenylate cyclase system during chronic exposure to an A1 adenosine receptor agonist: alterations in the quantity of GS alpha and Gi alpha are not associated with changes in their mRNAs.

G. Stiles, M. Blaustein, J. Stegeman, 1989, Molecular pharmacology.

Binding and uptake of diphtheria toxin by toxin-resistant Chinese hamster ovary and mouse cells

T. Moehring, J. Didsbury, J. Moehring, 1983, Molecular and cellular biology.

Functional high efficiency expression of cloned leucocyte chemoattractant receptor cDNAs

R. Snyderman, E. Tomhave, C. Gerard, 1992, FEBS letters.

Receptor class desensitization of leukocyte chemoattractant receptors.

R. Snyderman, E. Tomhave, J. Didsbury, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Differential regulation of cAMP by endogenous versus transfected formylpeptide chemoattractant receptors: implications for Gi-coupled receptor signaling.

R. Snyderman, T. Gettys, E. Tomhave, 1992, Biochemical and biophysical research communications.

Isoprenylation of the low molecular mass GTP-binding proteins rac 1 and rac 2: possible role in membrane localization.

R. Snyderman, J. Didsbury, R. J. Uhing, 1990, Biochemical and biophysical research communications.

Identification of the ral and rac1 gene products, low molecular mass GTP-binding proteins from human platelets.

R. Snyderman, P. Polakis, T. Evans, 1989, The Journal of biological chemistry.

Differences in the regulation of messenger RNA for housekeeping and specialized-cell ferritin. A comparison of three distinct ferritin complementary DNAs, the corresponding subunits, and identification of the first processed in amphibia.

Elizabeth C. Theil, Y. H. Wang, R. Kaufman, 1987, The Journal of biological chemistry.

Molecular cloning of a novel human GTP-binding protein and its potential role in chemoattractant stimulus-response coupling.

R. Snyderman, J. Didsbury, 1987, Transactions of the Association of American Physicians.

Multiple red cell ferritin mRNAs, which code for an abundant protein in the embryonic cell type, analyzed by cDNA sequence and by primer extension of the 5'-untranslated regions.

Elizabeth C. Theil, R. Kaufman, L. Dickey, 1986, The Journal of biological chemistry.

Both stimulatory and inhibitory GDP/GTP exchange proteins, smg GDS and rho GDI, are active on multiple small GTP-binding proteins.

K. Kaibuchi, M. Asada, E. Tomhave, 1992, Biochemical and biophysical research communications.

Rac1, a low-molecular-mass GTP-binding-protein with high intrinsic GTPase activity and distinct biochemical properties.

P. Casey, R. Snyderman, E. Tomhave, 1992, European journal of biochemistry.

rac, a novel ras-related family of proteins that are botulinum toxin substrates.

G M Bokoch, R. Snyderman, G. Bokoch, 1989, The Journal of biological chemistry.

Differences in phosphorylation of formylpeptide and C5a chemoattractant receptors correlate with differences in desensitization.

R. Snyderman, E. Tomhave, R. Richardson, 1993, The Journal of biological chemistry.

Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer's Disease.

S. M. de la Monte, M. Tong, J. Didsbury, 2016, Journal of Alzheimer's disease : JAD.

Targeting Alzheimer’s Disease Neuro-Metabolic Dysfunction with a Small Molecule Nuclear Receptor Agonist (T3D-959) Reverses Disease Pathologies

S. M. de la Monte, M. Tong, J. Didsbury, 2016, Journal of Alzheimer's disease & Parkinsonism.

T3D-959: A multi-faceted disease remedial drug candidate for the treatment of Alzheimer's disease

John Didsbury, Suzanne de la Monte, J. Didsbury, 2015, Alzheimer's & Dementia.

Chemoattractant stimulus-response coupling

R. Snyderman, J. Didsbury, R. J. Uhing, 1992 .

An Exploratory Phase IIa Study of the PPAR delta/gamma Agonist T3D-959 Assessing Metabolic and Cognitive Function in Subjects with Mild to Moderate Alzheimer’s Disease

W. Strittmatter, J. Didsbury, Hoda Gabriel, 2019, Journal of Alzheimer's disease : JAD.

Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α

M. Lambert, W. Rocque, S. Jin, 1997, Nature.

T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer's Disease.

M. Tong, J. Didsbury, Chetram Deochand, 2016, Journal of Alzheimer's disease : JAD.

Human Gi protein α‐subunit: deduction of amino acid structure from a cloned cDNA

R. Snyderman, Y. Ho, J. Didsbury, 1987 .

Molecular cloning of a new human G protein Evidence for two Giα‐like protein families

R. Snyderman, J. Didsbury, John R. Didsbury, 1987 .